Monday 19 October 2026 / Ollsocare
Ollsocare
올쏘케어
Ollsocare develops AI vision technology that measures joint range of motion and muscle strength from 2D camera video, and sells digital therapeutics for musculoskeletal rehabilitation.
South KoreaHealthtech
$2.6M
Series A, 19 October (34억2,000만원)
Lead investorDaewoong Investment
Other investorsJ&P Medi Partners, Korea Credit Guarantee Fund, Oreunpharm, Torus Ventures
Reported by1 source
What makes it different
The company offers a connected workflow from hospital assessment to at-home rehabilitation, spanning a medical device (Anapa PS), a digital therapeutic (Anapa ME) and a clinician portal (Anapa Hub), and it is reportedly used by 25 medical institutions in Korea.
Ollsocare develops AI vision technology that measures joint range of motion and muscle strength from 2D camera video, and sells digital therapeutics for musculoskeletal rehabilitation.
Founders
KJ
Kim Jong-ho
CEO
Funding history
Monday 19 October 2026
$2.6M Series A, led by Daewoong Investment